Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241511875 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alina E Perrone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Parasitología Dr. Mario Fatala Chaben-ANLIS-Malbrán, Av. Paseo Colón 568, Buenos Aires 1063, Argentina. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Trypanocidal Agents, Cyclophilins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anlis Carlos G Malbrán, Scientific and Technological Research Fund (FONCyT), Argentina, Fondos Concursables de la ANLIS Carlos G. Malbrán 2015, IP A. Perrone.
Abstract (Originalsprache)
Cyclophilins (CyPs) are a family of enzymes involved in protein folding. Trypanosoma cruzi, the causative agent of Chagas disease, has a 19-kDa cyclophilin, TcCyP19, that was found to be secreted in parasite stages of the CL Brener clone and recognized by sera from T. cruzi-infected mice and patients. The levels of specific antibodies against TcCyP19 in T. cruzi-infected mice and subjects before and after drug treatment were measured by an in-house enzyme linked immunosorbent assay (ELISA). Mice in the acute and chronic phase of infection, with successful trypanocidal treatments, showed significantly lower anti-TcCyP19 antibody levels than untreated mice. In children and adults chronically infected with T. cruzi, a significant decrease in the anti-TcCyP19 titers was observed after 12 months of etiological treatment. This decrease was maintained in adult chronic patients followed-up 30–38 months post-treatment. These results encourage further studies on TcCyP19 as an early biomarker of trypanocidal treatment efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Nacional de Parasitología Dr. Mario Fatala Chaben-ANLIS-Malbrán, Av. Paseo Colón 568, Buenos Aires 1063, Argentina.
- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires 1063, Argentina.
ORCID-Profile: Alina E Perrone, Marcela S Rial, Marisa Fernández, Jacqueline Bua
Förderung
- Anlis Carlos G Malbrán
- Scientific and Technological Research Fund (FONCyT), Argentina
- Fondos Concursables de la ANLIS Carlos G. Malbrán 2015, IP A. Perrone
Zitieren
APA
Perrone, A. E., Pinillo, M., Rial, M. S., Fernández, M., Milduberger, N., González, C., Bustos, P. L., Fichera, L. E., Laucella, S. A., Albareda, M. C., & Bua, J. (2023). Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511875
Vancouver
Perrone AE, Pinillo M, Rial MS, Fernández M, Milduberger N, González C, et al. Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511875
BibTeX
@article{Perrone2023,
author = {Perrone, Alina E and Pinillo, Mariana and Rial, Marcela S and Fernández, Marisa and Milduberger, Natalia and González, Carolina and Bustos, Patricia L and Fichera, Laura E and Laucella, Susana A and Albareda, María Cecilia and Bua, Jacqueline},
title = {Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241511875}
}
EUVIMED